Skip to main content
Scienture Holdings, Inc. logo

Scienture Holdings, Inc. — Investor Relations & Filings

Ticker · SCNX ISIN · US89846A2078 US Manufacturing
Open in API
Filings indexed 495 across all filing types
Latest filing 2014-08-12 Director's Dealing
Country US United States of America
Listing US SCNX

About Scienture Holdings, Inc.

https://www.trxadehealth.com/

Scienture Holdings, Inc. is a holding company that operates through its subsidiaries, including Scienture, LLC and Integra Pharma Solutions, LLC. The company functions as an integrated pharmaceutical and health services provider focused on the development, commercialization, and distribution of novel specialty products. A key therapeutic area includes treatments for central nervous system disorders. Scienture Holdings aims to enhance value for patients and physicians by addressing the needs of underserved populations and bridging gaps in treatment delivery systems to improve healthcare outcomes. The company also provides a web-based purchasing platform for transactions.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2014-08-12 English
Regulatory Filings 2014
Regulatory Filings
2014-08-06 English
Regulatory Filings 2014
Regulatory Filings Classification · 100% confidence The document is a detailed response letter from Trxade Group, Inc. to the SEC staff regarding comments on their Registration Statement on Form 10 filed on June 11, 2014. The letter addresses specific SEC comments on disclosures, financial statements, accounting policies, and other regulatory requirements related to the Form 10 registration statement. It includes detailed explanations and revisions made to the Registration Statement and its exhibits. The presence of references to Regulation S-K items, accounting standards (FASB ASC), and the nature of the document as a comment letter response to a registration statement clearly identifies this as a Regulatory Filing (RNS). It is not an Annual Report, Earnings Release, or any other report type but a regulatory correspondence filing with the SEC. The document length and content confirm it is not a mere announcement or certification but a substantive regulatory filing.
2014-07-23 English
FORM 10-12G/A
Regulatory Filings Classification · 95% confidence The document is titled 'Amendment No. 1 to FORM 10' and is a General Form for Registration of Securities pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934. It includes detailed business descriptions, risk factors, financial information, and other comprehensive disclosures typical of a registration statement. The document is not an annual report (10-K), quarterly report (IR), or earnings release (ER), but rather a registration statement filing. The Form 10 is a regulatory filing used to register securities and is distinct from the annual or quarterly reports. Given the nature of the document as a registration statement and the absence of it being a report or announcement of a report, the best classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory filings that do not fit other categories.
2014-07-23 English
Regulatory Filings 2014
Regulatory Filings Classification · 95% confidence The document is a correspondence letter addressed to the SEC regarding comments on a Registration Statement on Form 10 filed by Trxade Group, Inc. It mentions the intention to submit an amendment to the Registration Statement. The document is short (1173 characters) and is a letter responding to regulatory comments rather than a financial report or announcement. It does not contain financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and correspondence with regulatory bodies.
2014-07-22 English
Regulatory Filings 2014
Regulatory Filings
2014-07-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.